TGFB1 and esophageal squamous cell carcinoma: In this study, we investigated the relationship between TGF-β1/Smad signaling and EMT in ESCC using recombinant TGF-β1 and SB431542, a potent inhibitor of ALK5 that inhibits TGF-β type II receptor, in human ESCC cell lines.